Prolonged survival of heart allografts transduced with AAV-CTLA4Ig
- 8 October 2003
- journal article
- Published by Wiley in Microsurgery
- Vol. 23 (5) , 489-493
- https://doi.org/10.1002/micr.10181
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Tropism-Modified Adenoviral and Adeno-Associated Viral Vectors for Gene TherapyCurrent Gene Therapy, 2002
- Adeno-associated virus vectors for gene therapy: more pros than cons?Molecular Medicine Today, 2000
- Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldGene Therapy, 1999
- Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation?Cell, 1995
- New perspectives of C1328-137-mediated T cell costimulationImmunity, 1995
- Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors.Circulation, 1994
- TRANSPLANTATION TOLERANCE INDUCED BY CTLA4-Ig1Transplantation, 1994
- Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion.The Journal of Experimental Medicine, 1993
- The Role of the CD28 Receptor During T Cell Responses to AntigenAnnual Review of Immunology, 1993
- T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo.Proceedings of the National Academy of Sciences, 1992